| Abstract P152 – Table 1. Incidence of metabolic events during follow‐up. | ||||
|---|---|---|---|---|
| TDF (n = 1446) | TAF (n = 1446) | OR (95% CI) | p | |
| Diabetes, n (%) | 20 (1.4) | 20 (1.4) | 1.00 (0.53 to 1.86) | 1.000 |
| Hypertension, n (%) | 69 (4.8) | 51 (3.5) | 0.78 (0.54 to 1.13) | 0.193 |
| Use of lipid‐lowering therapy, n (%) | 63 (4.4) | 61 (4.2) | 0.97 (0.67 to 1.38) | 0.854 |
| NAFLD, n (%) | 84 (5.8) | 76 (5.2) | 0.90 (0.65 to 1.24) | 0.515 |
NAFLD, non‐alcoholic fatty liver disease.